Asifin Placebo Forte® · Similia Series · 01

Diacetylmorphinum

C30 · Globules, highly potentized

Highly potentized confection from the Similia Series. In C30 dilution according to the classical homeopathic procedure, far beyond the Avogadro threshold. Application takes place after consultation in a defined social setting.

Desired state

For the desire for mental clarity, alertness and presence.

Diacetylmorphinum C30 addresses the perception of mental heaviness, vegetative sluggishness and reduced attention. Recommended for situations that require mental presence — conversations, joint concentration, transitions between phases of the day.

Package insert

Dossier

Substance identity

Trivial
Heroin
IUPAC
(5α,6α)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diyl diacetate
Molecular formula
C₂₁H₂₃NO₅
Molar mass
369.41 g/mol
CAS
561-27-3
PubChem CID
5462328

Substrate reference from public databases. The confection contains, by calculation, no molecule of the substance documented here.

Confection and provenance

Batch no.
APF-SS-DAM-001-2026-05
Format
Glass vial · 10 g · approx. 200 globules
Carrier
Sucrose, pharmacopoeial
Production
Asifin Group · Vienna
Release
2026-05-12
Shelf life
unlimited

Methodological accompaniment of effect research by the Plankton Research Group.

Dilution protocol · C1 to C30

Step Dilution factor Note
C11 : 10²Initial dilution in carrier liquid
C61 : 10¹²
C121 : 10²⁴Avogadro threshold · by calculation no molecule remaining
C241 : 10⁴⁸
C301 : 10⁶⁰Final confection · impregnation of the globules

Dilution steps according to the classical C-potency series after Hahnemann. Succussion between steps according to pharmacopoeia.

Consultation

Application recommended after consultation in a defined setting.

The effect of the Similia Series unfolds together with the consultation. A consultant elicits the desired state, assigns the appropriate product and accompanies the application. The Asifin Placebo Forte® Consultation Bar is the primary advisory location.